Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Nausea × Thalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 77 Neoplasms, Plasma Cell 24 Central Nervous System Neoplasms 11 Glioblastoma 10 Recurrence 9 Neoplasms 9 Brain Neoplasms 9 Gliosarcoma 8 Carcinoma, Hepatocellular 8 Glioma 6 Waldenstrom Macroglobulinemia 5 Prostatic Neoplasms 5 Melanoma 5 Lung Neoplasms 5 Leukemia 5 Carcinoma, Non-Small-Cell Lung 5 Lymphoma, Mantle-Cell 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Immunoglobulin Light-chain Amyloidosis 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Astrocytoma 4 Oligodendroglioma 3 Neuroblastoma 3 Myeloproliferative Disorders 3 Medulloblastoma 3 Kidney Neoplasms 3 Colonic Neoplasms 3 Breast Neoplasms 3

Interventions

Dexamethasone 25 Aprepitant 23 Palonosetron 18 Ondansetron 18 Calcium Dobesilate 13 Olanzapine 12 Granisetron 11 Therapeutics 7 fosaprepitant 6 Doxorubicin 6 Cyclophosphamide 6 dexamethasone acetate 5 netupitant 4 Vincristine 4 dolasetron 3 Tropisetron 3 Prochlorperazine 3 Metoclopramide 3 Lorazepam 3 Dronabinol 3 Acupressure 3 peppermint oil 2 netupitant, palosentron drug combination 2 ginger extract 2 dexamethasone 21-phosphate 2 Surveys and Questionnaires 2 Sugars 2 Rituximab 2 Radiotherapy 2 Psychiatric Rehabilitation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06017284 2023-11-24

PTCA199-5

Fudan University

Phase 3 Recruiting

Gastrointestinal

Nausea, Pancreatic Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡